https://adisinsight.springer.com/trials/700392429?error=cookies_not_supported&code=7ab03770-52dd-4366-a189-7bd188f94d85
A Single-Arm, Multicenter, Phase II Study of MRG003 Combined With QL1706 for Second-Line or Later...
This is a single-arm, multicenter, phase II study designed to evaluate the efficacy and safety of MRG003, an anti-EGFR antibody-drug conjugate, in combination